The market for RNA Polymerase I (Pol I) inhibitors is a nascent, highly specialized area of oncology drug discovery with strong biological rationale. Polymerase I is the enzyme that transcribes ...
The discovery shows that the production of ribosomal RNA (rRNA) is connected to how cells manage RNA splicing (a process that edits RNA). In studies of cancer cell lines using drugs that block rRNA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results